Monthon Lertcanawanichakul

Dr. Monthon Lertcanawanichakul

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in PeerJ
Verified
Journal Article
Open access
PDF file
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
TSTuanhawanti Sahabuddeen
Tuanhawanti Sahabuddeen
Background: Bioactive compounds (BCs) from natural resources have been extensively studied because of their use as models in the development of novel and important medical and biopreservative agents. One important source of BCs is microorganisms, particularly terrestrial bacteria of the order Actinomycetales. Methods: We characterized Streptomyces sp. KB1 by observing its morphology, physiology, and growth on different media using biochemical tests, optimizing cultural conditions by changing one independent variable at a time. Results: Streptomyces sp. KB1 (TISTR 2304) is a gram-positive and long filamentous bacteria that forms straight to flexuous (rectiflexibile) chains of globose-shaped and smooth-surfaced spores. It can grow under aerobic condition s only at a temperature range of 25–37 °C and initial pH range of 5–10 in the presence of sodium chloride 4% (w/v). Therefore, it is considered an obligate aerobe, mesophilic, neutralophilic, and moderately halophilic bacteria. The isolate grew well on peptone-yeast extract iron, Luria Bertani (LB), and a half-formula of LB (LB/2), but could not grow on MacConkey agar. It utilized fructose, mannose, glucose, and lactose as its carbon source along with acid production and showed positive reactions to casein hydrolysis, gelatin liquefaction, nitrate reduction, urease, and catalase production. Streptomyces sp. KB1 (TISTR 2304) could produce the maximum number of BCs when 1% of its starter was cultivated in a 1,000 ml baffled flask containing 200 ml of LB/2 broth with its initial pH adjusted to 7 with no supplemental carbon source, nitrogen source, NaCl, or trace element at 30 °C, shaken at 200 rpm in an incubator for 4 days.

14 November 2025 in Molecules
Verified
Journal Article
Open access
PDF file
HMHusna Madoramae
Husna Madoramae
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
Red palm oil (RPO) is a rich source of bioactive compounds, including carotenoids, tocopherols, tocotrienols, and polyphenols, which contribute to its potent antioxidant and anti-inflammatory properties. This review summarizes the current understanding of RPO composition, bioactivity, and potential applications in health and cosmetics. Current preclinical and small-scale clinical studies suggest that RPO bioactives can mitigate oxidative stress, modulate inflammatory pathways, and improve skin barrier function. Strategies to enhance stability and bioavailability, such as microencapsulation and formulation into emulsions or liposomes, are also discussed. The manuscript highlights the potential of RPO as a natural functional ingredient in dietary, nutraceutical, and cosmetic products. Comprehensive evaluation of these bioactive compounds provides insights for future research and practical applications in promoting human health.

2 October 2023 in PeerJ
Verified
Journal Article
Open access
PDF file
AOAbiodun Ogunsile
Abiodun Ogunsile
NSNuttapon Songnaka
Nuttapon Songnaka
SSSomchai Sawatdee
Somchai Sawatdee
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
SKSucheewin Krobthong
Sucheewin Krobthong
AAApichart Atipairin
Apichart Atipairin
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is listed as a highly prioritized pathogen by the World Health Organization (WHO) to search for effective antimicrobial agents. Previously, we isolated a soil Brevibacillus sp. strain SPR19 from a botanical garden, which showed anti-MRSA activity. However, the active substances were still unknown. Methods: The cell-free supernatant of this bacterium was subjected to salt precipitation, cation exchange, and reversed-phase chromatography. The antimicrobial activity of pure substances was determined by broth microdilution assay. The peptide sequences and secondary structures were characterized by tandem mass spectroscopy and circular dichroism (CD), respectively. The most active anti-MRSA peptide underwent a stability study, and its mechanism was determined through scanning electron microscopy, cell permeability assay, time-killing kinetics, and biofilm inhibition and eradication. Hemolysis was used to evaluate the peptide toxicity. Results: The pure substances (BrSPR19-P1 to BrSPR19-P5) were identified as new peptides. Their minimum inhibition concentration (MIC) and minimum bactericidal concentration (MBC) against S. aureus and MRSA isolates ranged from 2.00 to 32.00 and 2.00 to 64.00 µg/mL, respectively. The sequence analysis of anti-MRSA peptides revealed a length ranging from 12 to 16 residues accompanied by an amphipathic structure. The physicochemical properties of peptides were predicted such as pI (4.25 to 10.18), net charge at pH 7.4 (−3 to +4), and hydrophobicity (0.12 to 0.96). The CD spectra revealed that all peptides in the water mainly contained random coil structures. The increased proportion of α-helix structure was observed in P2−P5 when incubated with SDS. P2 (NH2-MFLVVKVLKYVV-COOH) showed the highest antimicrobial activity and high stability under stressed conditions such as temperatures up to 100 °C, solution of pH 3 to 10, and proteolytic enzymes. P2 disrupted the cell membrane and caused bacteriolysis, in which its action was dependent on the incubation time and peptide concentration. Antibiofilm activity of P2 was determined by which the half-maximal inhibition of biofilm formation was observed at 2.92 and 4.84 µg/mL for S. aureus TISTR 517 and MRSA isolate 2468, respectively. Biofilm eradication of tested pathogens was found at the P2 concentration of 128 µg/mL. Furthermore, P2 hemolytic activity was less than 10% at concentrations up to 64 µg/mL, which reflected the hemolysis index thresholds of 32. Conclusion: Five novel anti-MRSA peptides were identified from SPR19. P2 was the most active peptide and was demonstrated to cause membrane disruption and cell lysis. The P2 activity was dependent on the peptide concentration and exposure time. This peptide had antibiofilm activity against tested pathogens and was compatible with human erythrocytes, supporting its potential use as an anti-MRSA agent in this post-antibiotic era.

15 January 2026 in Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
PBPhuangthip Bhoopong
Phuangthip Bhoopong
HMHusna Madoramae
Husna Madoramae
TSTuanhawanti Sahabuddeen
Tuanhawanti Sahabuddeen
Probiotics and microbiome-based therapeutics are increasingly used to prevent antibiotic-associated diarrhea (AAD) and support gut microbiota health across children, adults, and elderly populations. Evidence synthesized in this narrative review from randomized controlled trials and meta-analyses (>20,000 participants) suggests that early probiotic administration, particularly Lactobacillus rhamnosus GG, Bifidobacterium species, multistrain formulations, and Saccharomyces boulardii, is associated with a 30–40% relative reduction in AAD incidence across heterogeneous studies, with absolute risk reductions of approximately 5–12% depending on baseline risk, strain, dose, and timing. Probiotics are generally well tolerated, with mild gastrointestinal adverse effects reported in 3–5% of users and rare serious events mainly in immunocompromised individuals. However, heterogeneity in formulations, populations, and limited long-term real-world data underscores the need for further pharmacoepidemiological studies, microbiome surveillance, and evaluation of antimicrobial resistance implications.

6 February 2025 in Heliyon
Verified
Journal Article
Open access
HMHusna Madoromae
Husna Madoromae
AAApichart Atipairin
Apichart Atipairin
MTMalatee Tayeh
Malatee Tayeh
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul
The rise in antimicrobial-resistant (AMR) bacteria, especially Methicillin-resistant Staphylococcus aureus (MRSA), is a global health concern. Bacteriocins are promising antibiotic alternatives. This study aimed to enhance the production of bacteriocin-like substances (BLS) from Brevibacillus laterosporus SA-14 (TISTR 2453) by optimizing nutrients, evaluating antibacterial activity, assessing synergy with vancomycin, and testing the cytotoxicity and wound healing effects on human keratinocytes. The results showed that when the SA-14 strain was cultured in half-formula Luria-Bertani broth (LB/2) with added carbon sources (glucose, sucrose, and lactose), all cultures reached the late log phase at 24 h, and antibacterial activity was exhibited against various MRSA strains after 48 h, except for the LB/2 supplemented with glucose, likely due to carbon catabolite repression. However, the addition of nitrogen sources, including skim milk, peptone, and beef extract resulted in high antibacterial activity at 48 h, with skim milk being the most effective for BLS production. The BLS was precipitated with 80 % ammonium sulfate, achieving a 38.09 % yield and a protein concentration of 6.97 ± 1.12 mg/mL. The SDS-PAGE analysis revealed five bands of proteins with molecular weights of 25–250 kDa. The minimum inhibitory concentration of BLS ranged from 0.44 to 0.87 mg/mL, with an minimum bactericidal concentration) of 0.87 mg/mL for all MRSA strains. A synergistic effect with vancomycin was observed at 0.22 mg/mL BLS and 1 μg/mL vancomycin, with an fractional inhibitory concentration index of 1.00, indicating an additive effect. At a concentration of 0.22 mg/mL, BLS was non-cytotoxic to HaCaT cells and promoted complete wound healing after 48 h. Therefore, BLS produced by the SA-14 strain is suitable for controlling AMR, especially MRSA, and has the potential for application in wound dressings in the future.

2 December 2025 in Food and Humanity
Verified
Journal Article
Closed access
HMHusna Madoramae
Husna Madoramae
PBPhuangthip Bhoopong
Phuangthip Bhoopong
MLMonthon Lertcanawanichakul
Monthon Lertcanawanichakul